Drug recall
Red Blood Cells
FDA recall event 79572 · Class III · Dept. of the Navy - U.S. Naval Hospital
Key facts
| Event ID | 79572 |
|---|---|
| Recall numbers | B-0441-2018 |
| Recalling firm | Dept. of the Navy - U.S. Naval Hospital |
| Product type | Biologics |
| Products | Red Blood Cells |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, not properly tested for relevant transfusion transmitted infections, were distributed. |
| Initiation date | Oct 31, 2017 |
| Report date | Mar 28, 2018 |
| Termination date | Mar 22, 2018 |
| City | Ginowan City (Okinawa) |
| Country | Japan |
| FEI number | 3002809469 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: